Jamie Zeitzer

Professional Education

Graduate & Fellowship Program Affiliations

• Neurosciences
• Psychiatry and Behavioral Science

Research Interests

Dr. Zeitzer's research concerns examination of human and primate circadian rhythms and sleep; notably, the neural mechanisms that underlie wakefulness and circadian photoreception. He is also involved in collaborative efforts in examining the role of sleep disruption in medical pathologies such as Alzheimer's disease, spinal cord injury, and breast cancer.

Clinical Trials

• Melatonin Replacement for Treatment of Sleep Disruption in Tetraplegia Recruiting
• Modafinil Treatment for Sleep/Wake Disturbances in Older Adults Recruiting
• Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival Recruiting

Publications

• Modafinil and gamma-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep. Zeitzer JM, Buckmaster CL, Landolt HP, Lyons DM, Mignot E. Behav Pharmacol. 2009
• Scheduled bright light for treatment of insomnia in older adults. Friedman L, Zeitzer JM, Kushida C, Zhdanova I, Noda A, Lee T, Schneider B, Guilleminault C, Sheikh J, Yesavage JA. J Am Geriatr Soc. 2009; 57 (3): 441-52
• Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. Palesh O, Zeitzer JM, Conrad A, Giese-Davis J, Mustian KM, Popek V, Nga K, Spiegel D. J Clin Sleep Med. 2008; 4 (5): 441-9
• CSF hypocretin-1 assessment in sleep and neurological disorders. Bourgin P, Zeitzer JM, Mignot E. Lancet Neurol. 2008; 7 (7): 649-62
• Decreased sensitivity to phase-delaying effects of moderate intensity light in older subjects. Duffy JF, Zeitzer JM, Czeisler CA. Neurobiol Aging. 2007; 28 (5): 799-807